TABLE 1.
Demographic and clinical characteristics of cases. (Group 1: cases not associated with cardiac defects, Group 2: cases associated with cardiac defects).
| Group 1 (n=16) | Group 2 (n=15) | Total (%) (n=31) | |
|---|---|---|---|
| Age (mean±SD, year)* | 30.1±3.5 | 29.5±6.1 | 29.8±4.9 |
| GAD (mean±SD, week)* | 24.1±4 | 25±5.2 | 24.5±4.6 |
| Fetal gender* | (n=13) | (n=15) | (n=28) |
| Male | 7 (53.8) | 10 (66.6) | 17 (60.8) |
| Female | 6 (46.2) | 5 (33.3) | 11 (39.2) |
| Extracardiac anomalies* | 8 (50) | 9 (60) | 17 (54.8) |
| Karyotype* | (n=14) | (n=12) | (n=26) |
| Normal | 13 (92.8) | 11 (91.7) | 24 (92.3) |
| Aneuploidy | 1 (7.2) | 1 (8.3) | 2 (7.7) |
| Outcome† | (n=13) | (n=15) | (n=28) |
| Favorable | 11 (84.6) | 5 (33.3) | 16 (57.2) |
| Unfavorable | 2 (15.4) | 10 (66.6) | 12 (42.8) |
GAD: gestational age at diagnosis (Unfavorable outcome includes neonatal death, termination of pregnancy and in utero death)
*
Group 1 vs. Group 2 is insignificant (p>0.05)
†
Group 1 vs. Group 2 is significant (p=0.009)